Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer
Subscribe to Our Newsletter
You are leaving this research use-only area
You are about to access content intended for a different region. Information, regulatory status, and product availability may vary by location.
